Miguel Ángel Von-Wichmann

Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus†

Juan Berenguer, Pilar Miralles Martín, José López‐Aldeguer et al. · Hepatology · 2009 · 295 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

A Howe, Chaturaka Rodrigo, Evan B. Cunningham et al. · JHEP Reports · 2022 · 42 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +16

Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

Juan Berenguer, Francisco Zamora, Teresa Aldámiz‐Echevarría et al. · Clinical Infectious Diseases · 2014 · 40 citations · Full text

Medicine, Infectious Diseases, Pathology +12

Pegylated interferon  2a plus ribavirin versus pegylated interferon  2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

Juan Berenguer, Juan González‐García, José López-Aldeguer et al. · Journal of Antimicrobial Chemotherapy · 2009 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

Juan Berenguer, M. A. von Wichmann, Carmen Quereda et al. · Journal of Antimicrobial Chemotherapy · 2011 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17